Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

GDC-0326

Copy Product Info
😃Good
Catalog No. T3985Cas No. 1282514-88-8
Alias GDC0326, GDC 0326

GDC-0326 is a potent and selective inhibitor of the α-isoform of Phosphoinositide 3-Kinase (PI3Kalpha inhibitor).

GDC-0326

GDC-0326

Copy Product Info
😃Good
Purity: 99.35%
Catalog No. T3985Alias GDC0326, GDC 0326Cas No. 1282514-88-8
GDC-0326 is a potent and selective inhibitor of the α-isoform of Phosphoinositide 3-Kinase (PI3Kalpha inhibitor).
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$30In StockIn Stock
2 mg$45In StockIn Stock
5 mg$87In StockIn Stock
10 mg$157In StockIn Stock
25 mg$268In StockIn Stock
50 mg$428In StockIn Stock
100 mg$623-In Stock
1 mL x 10 mM (in DMSO)$95In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.35%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

GDC-0326 AI Summary
GDC-0326 exhibits a range of bioactivities, including high inhibitory activity against multiple Cytochrome P450 enzymes (CYP3A4, CYP2C9, CYP1A2, CYP2C19, and CYP2D6) with IC50 values greater than 10000.0 nM. It has good apparent permeability in MDCK cells and moderate selectivity for PI3K isoforms. The compound demonstrates antiproliferative activity against MCF7-neo/Her2 cells and PC3 cells with EC50 values of 100.0 nM and 2200.0 nM, respectively, and cytotoxicity against KPL4 cells with an EC50 value of 60.0 nM. GDC-0326 displays significant antitumor activity in xenografted mouse models, with tumor growth inhibition ranging from 73.0% to 110.0% at varying doses, and decreases phosphorylated Akt levels in MCF7-neo/Her2 xenografted mice. It shows potent inhibition of PI3Kalpha with a Ki value of 0.2 nM and notable selectivity for PI3Kalpha over PI3Kdelta (ratio Ki of 22.0). It inhibits the H1047R mutant of PI3Kalpha in human HCC1954 cells, reducing PRAS40 phosphorylation with an EC50 of 89.0 nM, and has slight selectivity for mutant over wild type PI3Kalpha (ratio EC50 of 1.4). Also, the compound inhibits PI3Kdelta in human B-cells, reducing CD69 expression with an IC90 of 147.0 nM and demonstrates low toxicity, indicated by minimal body weight loss in toxicity assays. Its lipophilicity, measured as LogD in 1-Octanol/PBS at pH 7.4, is 1.9. GDC-0326 has good oral bioavailability and plasma protein binding across different animal models..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
GDC-0326 is a potent and selective inhibitor of the α-isoform of Phosphoinositide 3-Kinase (PI3Kalpha inhibitor).
Targets&IC50
PI3Kα:0.2 nM(Ki), PI3Kγ:10.2 nM(Ki), PI3Kβ:26.6 nM(Ki), PI3Kδ:4 nM(Ki)
SynonymsGDC0326, GDC 0326
Chemical Properties
Molecular Weight382.42
FormulaC19H22N6O3
Cas No.1282514-88-8
SmilesCC(C)n1ncnc1-c1cn2CCOc3cc(O[C@@H](C)C(N)=O)ccc3-c2n1
Relative Density.1.44 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 69 mg/mL (180.43 mM), Sonication is recommended.
H2O: Insoluble
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.23 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.6149 mL13.0746 mL26.1493 mL130.7463 mL
5 mM0.5230 mL2.6149 mL5.2299 mL26.1493 mL
10 mM0.2615 mL1.3075 mL2.6149 mL13.0746 mL
20 mM0.1307 mL0.6537 mL1.3075 mL6.5373 mL
50 mM0.0523 mL0.2615 mL0.5230 mL2.6149 mL
100 mM0.0261 mL0.1307 mL0.2615 mL1.3075 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GDC-0326 | purchase GDC-0326 | GDC-0326 cost | order GDC-0326 | GDC-0326 chemical structure | GDC-0326 formula | GDC-0326 molecular weight